FDA advisers: Ortho Evra patch needs clearer label
ADELPHI, Maryland (Reuters) - U.S. drug advisers recommended that the label for Johnson And Johnson's Ortho Evra birth control patch be simplified to better explain the risk of blood clots. In a 20 to 3 vote with one abstention, advisers to the Food And Drug Administration found that the current label for Ortho Evra inadequately reflects the risks women face by using it. It is the only contraceptive patch sold in the United States. The panel voted 19 to 5 that the patch's risks were outweighed by its benefits, such as pregnancy prevention through a once-weekly application. ... read more..
source:yahoo.com
No comments:
Post a Comment